#12954 on the rich list of 14,644 insiders
Nicholas Augustinos
Director at DexCom. Based in San Diego, California.
$5.9M
in disclosed stock, −$171K (−2.82%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 12954th of 14,644
- Companies held
- 1
- Largest holding
- DXCM, 100.0% of total
- Latest SEC filing
- Sep 15, 2026
What the $5.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| DexCom DXCM Common Stock | Indirectly (see filing footnote) | 38,457 | $80.19 | $3.1M | 52.4% | Form 4, May 8, 2026 |
| DexCom DXCM Common Stock | Through Trust | 29,293 | $80.19 | $2.3M | 39.9% | Form 4, Sep 15, 2026 |
| DexCom DXCM Common Stock | Directly | 5,575 | $80.19 | $447K | 7.6% | Form 4, Sep 14, 2026 |
Share counts are the amounts Nicholas Augustinos reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12951 | Nick Pizzie Chief Financial Officer, Axsome Therapeutics. New York, NY | $5.9M |
| 12952 | Robert J. Andersen Former Chief Financial Officer, Adeia. San Jose, CA | $5.9M |
| 12953 | Ross Muken Chief Executive Officer, SOPHiA GENETICS SA. Boston, MA | $5.9M |
| 12954 | Nicholas Augustinos Director, DexCom. San Diego, CA | $5.9M |
| 12955 | James T. Thompson Director, Hawkins. Roseville, MN | $5.9M |
| 12956 | Scott A. Richardson CEO & President, Celanese. Irving, TX | $5.9M |
| 12957 | Jeffrey B. Citrin Director, Tanger. Greensboro, NC | $5.9M |
Other DexCom insiders
All DXCM insiders- Eric Topol$60.8MDirector. #2212 overall
- Jacob Steven Leach$37.3MPresident, CEO, and Director. #3168 overall
- Kevin R. Sayer$24.2MExecutive Chair. #4481 overall
- Donald Abbey$16.7MEVP Global Business Services I. #5675 overall
- Mark G. Foletta$13.1MDirector. #6639 overall
- Jereme M. Sylvain$11.7MEVP, COO & CFO. #7832 overall
Questions
How much stock does Nicholas Augustinos own?
Nicholas Augustinos holds $5,879,932 in listed stock based on SEC filings and current prices, mostly DexCom (DXCM). That ranks 12954th on the Stock Rich List.
Is this Nicholas Augustinos's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Nicholas Augustinos last buy or sell stock?
The most recent open-market trade on file is a sale of 6,539 DXCM shares on Sep 15, 2026 at $84.04.